Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Maxcyte Inc
(NQ:
MXCT
)
4.380
+0.260 (+6.31%)
Streaming Delayed Price
Updated: 12:47 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Maxcyte Inc
< Previous
1
2
3
4
Next >
MaxCyte Announces CEO Transition and Updates Revenue Guidance for 2023
December 11, 2023
From
MaxCyte, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 06, 2023
Via
Benzinga
MaxCyte Joins the Alliance for mRNA Medicines (AMM) as a Founding Member
November 16, 2023
MaxCyte continues supporting the advancement of novel therapeutics and looks to support education and advancement of mRNA medicines
From
MaxCyte, Inc
Via
GlobeNewswire
Recap: MaxCyte Q3 Earnings
November 08, 2023
Via
Benzinga
MaxCyte Reports Third Quarter 2023 Financial Results and Reiterates Full Year 2023 Revenue Guidance
November 08, 2023
From
MaxCyte, Inc
Via
GlobeNewswire
MaxCyte to Participate in Two Upcoming Investor Conferences
November 06, 2023
From
MaxCyte, Inc
Via
GlobeNewswire
Cell Engineering MaxCyte Faces Challenge, Analysts Express Concerns Over Near-Term Prospects Amid Revenue Decline
October 05, 2023
MaxCyte Inc (NASDAQ: MXCT) shares plummeted after the company released preliminary Q3 revenue of $7.8 million – 8.0 million, a Y/Y decrease of 25 -27%, due to continued reduced
Via
Benzinga
Crude Oil Down 2%; ConAgra Brands Earnings Top Views
October 05, 2023
U.S. stocks traded slightly lower toward the end of trading, with the Dow Jones index falling around 40 points on Thursday. The Dow traded down 0.12% to 33,088.44 while the NASDAQ fell 0.23% to...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
October 05, 2023
Via
Benzinga
Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
October 05, 2023
Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by Japan's Kyowa Kirin for $16.00 per ADS in cash plus an additional contingent...
Via
Benzinga
Why Shares of MaxCyte Are Plummeting on Thursday
October 05, 2023
The biotech company reduced full-year guidance and expects so-so third-quarter revenue.
Via
The Motley Fool
Dow Tumbles Over 100 Points; Constellation Brands Raises Profit Forecast
October 05, 2023
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.45% to 32,980.31 while the NASDAQ fell 0.62% to 13,154.24. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
BB Stock Alert: What to Know as BlackBerry Plans IPO for IoT Division
October 05, 2023
BlackBerry stock is a hot topic among BB shareholders today alongside news the company is considering an IPO for its IoT business.
Via
InvestorPlace
Topics
Initial Public Offering
Exposures
Securities Market
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 05, 2023
Via
Benzinga
Why Is MaxCyte (MXCT) Stock Down 21% Today?
October 05, 2023
MaxCyte stock is taking a beating on Thursday as investors in MXCT shares react to preliminary results for its third quarter of 2023.
Via
InvestorPlace
Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket
October 05, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
October 05, 2023
Pre-market stock movers are rising and falling on Thursday as we check out all of the latest news worth knowing about this morning!
Via
InvestorPlace
MaxCyte, Rivian Automotive And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
October 05, 2023
U.S. stock futures traded lower this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Conagra Brands, Constellation Brands And 3 Stocks To Watch Heading Into Thursday
October 05, 2023
With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 04, 2023
Via
Benzinga
MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance
October 04, 2023
From
MaxCyte, Inc
Via
GlobeNewswire
MaxCyte Appoints Ali Soleymannezhad as Executive Vice President of Bioprocessing
September 06, 2023
From
MaxCyte, Inc
Via
GlobeNewswire
MaxCyte to Participate in Baird Global Healthcare Conference
September 05, 2023
From
MaxCyte, Inc
Via
GlobeNewswire
MaxCyte Reports Second Quarter and Half-Year 2023 Financial Results and Updates Full Year 2023 Guidance
August 09, 2023
From
MaxCyte, Inc
Via
GlobeNewswire
MaxCyte Signs Strategic Platform License with Prime Medicine to Advance Next-Generation Gene Editing Therapies for Patients
August 01, 2023
Prime Medicine to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to advance their innovative Prime Editing technology and develop a new class of one-time, potentially curative...
From
MaxCyte, Inc
Via
GlobeNewswire
MaxCyte to Report Second Quarter 2023 Financial Results on August 9, 2023
July 13, 2023
From
MaxCyte, Inc
Via
GlobeNewswire
MaxCyte and Vittoria Biotherapeutics Sign Strategic Platform License to Advance Next Generation Cellular Therapies
July 10, 2023
MaxCyte’s Flow Electroporation® technology and ExPERT™ platform will support Vittoria’s Senza5™ technology to enhance efficacy and improve clinical utility of T-cell therapies.
From
MaxCyte, Inc
Via
GlobeNewswire
MaxCyte Signs Strategic Platform License with Lyell Immunopharma
July 06, 2023
From
MaxCyte, Inc
Via
GlobeNewswire
MaxCyte to Participate in Upcoming Investor Conferences
June 01, 2023
From
MaxCyte, Inc
Via
GlobeNewswire
Why Groupon Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
May 11, 2023
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) gained 109.8% to $1.06 after reporting a rise in Q1 sales.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.